Companies/Radiko Holdings Corp

Company profile

Radiko Holdings Corp

OTC: GEATF · Healthcare · Medical - Pharmaceuticals

PublicHQ Los Angeles, WAReports USD

#698 of 1,394 Healthcare companies by revenuetop-decile growth

EA Score

——

FH —DQ —GM —SS 31

v0.1 · 5/100 weight · pillars only

↑ revenue growth (YoY), 3-yr revenue growth · ↓ growth stability, market scale

Methodology →

Revenue TTM

$3.2M

Rev growth YoY (TTM)

-30.5%

Net income (FY)

-$10.6M

Employees

Market cap

$4.5k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$5.2M$5.2M2019

Net income-$10.6M-$10.6M2019

Operating income-$10.5M-$10.5M2019

Total assets$2.7M$2.7M2019

Liabilities$4.7M$4.7M2019

Equity-$2.7M-$2.7M2019

Revenue trend

FY2012 – FY2019 · USD

FY12

FY13

FY14

FY15

$382.5k

FY16

$143.3k

FY17

$101.1k

FY18

$5.2M

FY19

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Radiko Holdings Corp booked $5.2M in FY2019 revenue, growing 5022% year over year — faster than 99% of Healthcare companies we track, at a -205.5% net margin.

Peers · Healthcare

Aridis Pharmaceuticals, Inc.——Ingen Technologies, Inc.——Innovation1 Biotech Inc.——Baudax Bio, Inc.——

Key facts

CEOPierluigi Paracchi

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersLos Angeles, WA

ExchangeOTC: GEATF

Employees22

IPO date2017-11-08

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.